{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:02:18Z","timestamp":1781078538678,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015034","name":"Shahid Sadoughi University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014351","name":"CinnaGen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005421","name":"Guilan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.msard.2025.106824","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:01:22Z","timestamp":1761786082000},"page":"106824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS \u2013infectious disease group"],"prefix":"10.1016","volume":"105","author":[{"given":"Sepideh","family":"Paybast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzie","family":"Abutorabi-zarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Ashtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mohammad","family":"Baghbanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid Beladi","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Eidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza Ghalyanchi","family":"Langroodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Majdinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-5524","authenticated-orcid":false,"given":"Farzad","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Nahayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Navardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nikseresht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Poursadeghfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Razazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid Shaygan","family":"Nezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Esmailpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdehagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Iranshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-7114","authenticated-orcid":false,"given":"Amir Reza","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106824_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7224\/1537-2073.2019-030","article-title":"Prevalence of lower urinary tract symptoms in people with Multiple sclerosis","volume":"22","author":"Al Dandan","year":"2020","journal-title":"Int. J. MS. Care"},{"key":"10.1016\/j.msard.2025.106824_bib0002","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0956462420946662","article-title":"Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series","volume":"31","author":"Alfano","year":"2020","journal-title":"Int. J. STD. AIDS"},{"key":"10.1016\/j.msard.2025.106824_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105009","article-title":"Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: pathogenesis, risk of infection, and disease management","volume":"79","author":"Alvarez","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0004","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/molecules26041132","article-title":"Advances and perspectives in the management of Varicella-Zoster Virus infections","volume":"26","author":"Andrei","year":"2021","journal-title":"Molecules."},{"key":"10.1016\/j.msard.2025.106824_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/jcm13020393","article-title":"Hepatitis B virus reactivation with immunosuppression: a hidden threat?","volume":"13","author":"Anvari","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2025.106824_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105400","article-title":"Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis","volume":"82","author":"Baker","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cei\/uxab015","article-title":"Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?","volume":"207","author":"Baker","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0008","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.3390\/ijms24119231","article-title":"COVID-19: the course, vaccination and Immune response in people with Multiple sclerosis: systematic review","volume":"24","author":"Bazylewicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106824_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7224\/1537-2073.2019-015","article-title":"Prevalence of latent tuberculosis in the Multiple Sclerosis clinic and effect of multiple sclerosis treatment on tuberculosis testing","volume":"23","author":"Bouley","year":"2021","journal-title":"Int. J. MS. Care"},{"key":"10.1016\/j.msard.2025.106824_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01267-2017","article-title":"Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results","volume":"50","author":"Brown","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.msard.2025.106824_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00430-016-0482-x","article-title":"Effect of teriflunomide on QuantiFERON-TB Gold results","volume":"206","author":"Bua","year":"2017","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0012","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00415-022-11009-x","article-title":"Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study","volume":"269","author":"Buonomo","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0013","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2015.01.011","article-title":"Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice","volume":"14","author":"Cantini","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2025.106824_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection: new alternatives","volume":"11","author":"Carranza","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0015","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1007\/s00415-024-12333-0","article-title":"Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey","volume":"271","author":"\u00c7elik","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0016","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2014-206711","article-title":"A comparison of safety profiles of tumour necrosis factor \u03b1 inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C","volume":"74","author":"Chen","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0017","article-title":"Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis","volume":"8","author":"Chey","year":"2022","journal-title":"Mult. Scler. J. - Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106824_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy356","article-title":"Reactivation of Hepatitis B virus with immune-escape mutations after Ocrelizumab treatment for multiple sclerosis","volume":"6","author":"Ciardi","year":"2019","journal-title":"Open. Forum. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103184","article-title":"Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: a systematic review","volume":"55","author":"Dantas","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/pn-2022-003426","article-title":"Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines","volume":"23","author":"Dobson","year":"2023","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0021","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1007\/s00415-019-09391-0","article-title":"HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab","volume":"266","author":"Dudek","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1380654","article-title":"Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients","volume":"15","author":"Elgenidy","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy174","article-title":"Infectious complications of multiple sclerosis therapies: implications for screening, prophylaxis, and management","volume":"5","author":"Epstein","year":"2018","journal-title":"Open. Forum. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0024","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/14737175.2014.962517","article-title":"How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?","volume":"14","author":"Fragoso","year":"2014","journal-title":"Expert. Rev. NeurOther"},{"key":"10.1016\/j.msard.2025.106824_bib0025","first-page":"213","article-title":"Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs","volume":"68","author":"Gabutti","year":"2016","journal-title":"Minerva Pediatr."},{"key":"10.1016\/j.msard.2025.106824_bib0026","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200241","article-title":"A proposed approach to screening and surveillance labs for patients with multiple sclerosis on Anti-CD20 therapy","volume":"14","author":"Gandelman","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2025.106824_bib0027","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.msard.2025.106824_bib0028","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1093\/infdis\/jiaa573","article-title":"Live attenuated Varicella vaccine: prevention of Varicella and of Zoster","volume":"224","author":"Gershon","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.96.15_supplement.3062","article-title":"A case of VZV encephalitis associated with Ocrelizumab therapy (3062)","volume":"96","author":"Goyal","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106824_bib0030","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200253","article-title":"Practical considerations for managing pregnancy in patients with multiple sclerosis","volume":"14","author":"Graham","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2025.106824_bib0031","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3390\/microorganisms10101891","article-title":"Impact and tolerance of immunosuppressive treatments in patients living with HIV with inflammatory or autoimmune diseases","volume":"10","author":"Guitton","year":"2022","journal-title":"Microorganisms."},{"key":"10.1016\/j.msard.2025.106824_bib0032","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012700","article-title":"Safety of Ocrelizumab in patients with relapsing and primary progressive multiple sclerosis","volume":"97","author":"Hauser","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106824_bib0033","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood-2018-11-882167","article-title":"Resolved HBV and anti-CD20 therapy","volume":"133","author":"Hicks","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.msard.2025.106824_bib0034","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.msard.2025.106824_bib0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/hep4.1238","article-title":"Preventing Hepatitis B reactivation during anti-CD20 antibody treatment in the Veterans Health Administration","volume":"2","author":"Jasmine Bullard","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.msard.2025.106824_bib0036","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/tbed.13621","article-title":"Attributes of HIV infection over decades (1982-2018): a systematic review and meta-analysis","volume":"67","author":"Kabapy","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578178","article-title":"Disease modifying therapy and pregnancy outcomes in multiple sclerosis: a systematic review and meta-analysis","volume":"383","author":"Khan","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106824_bib0038","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419836571","article-title":"Risks and risk management in modern multiple sclerosis immunotherapeutic treatment","volume":"12","author":"Klotz","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0039","doi-asserted-by":"crossref","DOI":"10.4103\/aian.aian_205_23","article-title":"Efficacy of accelerated vaccination against Hbv to achieve antibody formation in multiple sclerosis patients receiving anti-Cd20 therapy","author":"Koc","year":"2023","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0040","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13311-022-01224-9","article-title":"Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management","volume":"19","author":"Krajnc","year":"2022","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.msard.2025.106824_bib0041","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s10067-019-04563-9","article-title":"Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis","volume":"38","author":"Krasselt","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.msard.2025.106824_bib0042","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40265-022-01672-9","article-title":"Ocrelizumab: a review in Multiple sclerosis","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2025.106824_bib0043","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.msard.2025.106824_bib0044","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200211","article-title":"Multiple sclerosis, Rituximab, hypogammaglobulinemia, and risk of infections","volume":"11","author":"Langer-Gould","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.msard.2025.106824_bib0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/children9020130","article-title":"Long-term Varicella zoster virus immunity in paediatric liver transplant patients can Be achieved by booster vaccinations\u2014A single-centre, retrospective, observational analysis","volume":"9","author":"Laue","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.msard.2025.106824_bib0046","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.3748\/wjg.v22.i28.6484","article-title":"Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy","volume":"22","author":"Law","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106824_bib0047","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jmii.2011.12.020","article-title":"Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis","volume":"46","author":"Lin","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.msard.2025.106824_bib0048","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00415-023-11973-y","article-title":"Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study","volume":"271","author":"Marzo","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578066","article-title":"Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD","volume":"377","author":"Mears","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106824_bib0050","article-title":"Urinary tract infection in patients with multiple sclerosis: an overview","volume":"46","author":"Junior","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0051","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/nau.24276","article-title":"Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis","volume":"39","author":"Medina-Polo","year":"2020","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.msard.2025.106824_bib0052","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10072-021-05750-w","article-title":"Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis","volume":"43","author":"Mirmosayyeb","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106824_bib0053","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458520952311","article-title":"The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: a Delphi consensus statement","volume":"27","author":"Moiola","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106824_bib0054","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acn3.51732","article-title":"Real-world evaluation of ocrelizumab in multiple sclerosis: a systematic review","volume":"10","author":"Montalban","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0055","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i36.10274","article-title":"Hepatitis B virus reactivation associated with antirheumatic therapy: risk and prophylaxis recommendations","volume":"21","author":"Mori","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106824_bib0056","article-title":"Diagnosis and management of latent tuberculosis infection: Table 1. Cold Spring Harb","volume":"5","author":"Mu\u00f1oz","year":"2015","journal-title":"Perspect. Med."},{"key":"10.1016\/j.msard.2025.106824_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103335","article-title":"COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: what we know by May 2021","volume":"57","author":"Naghavi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0058","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2025.106824_bib0059","article-title":"Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis","volume":"4","author":"Navas","year":"2018","journal-title":"Mult. Scler. J. - Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106824_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102988","article-title":"Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases","volume":"52","author":"Oksbjerg","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0061","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a Work Group report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees","volume":"149","author":"Otani","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0062","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/13524585231168043","article-title":"ECTRIMS\/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs","volume":"29","author":"Otero-Romero","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106824_bib0063","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/1744666X.2021.1886924","article-title":"Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment","volume":"17","author":"Otero-Romero","year":"2021","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0064","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00296-016-3575-3","article-title":"Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy","volume":"36","author":"Ozguler","year":"2016","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.msard.2025.106824_bib0065","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.neurol.2021.04.011","article-title":"Infections and multiple sclerosis: recommendations from the French Multiple Sclerosis Society","volume":"177","author":"Papeix","year":"2021","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0066","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/jpm12030507","article-title":"Impact of immunosuppressive therapy on the performance of latent tuberculosis screening tests in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Park","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.msard.2025.106824_bib0067","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hon.2900","article-title":"Immunoglobulin replacement therapy discontinuation in patients with antibody deficiency secondary to hematological malignancy","volume":"39","author":"Patel","year":"2021","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.msard.2025.106824_bib0068","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/1744666X.2020.1788939","article-title":"Discontinuation of immunoglobulin replacement therapy in patients with secondary antibody deficiency","volume":"16","author":"Patel","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0069","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.29082","article-title":"Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: a meta-analysis","volume":"66","author":"Paul","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.msard.2025.106824_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108554","article-title":"Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab","volume":"223","author":"Rapisarda","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2025.106824_bib0071","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of Hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.msard.2025.106824_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104090","article-title":"Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: a retrospective case series and a systematic review of reported cases","volume":"68","author":"Rossi","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.101596","article-title":"Epidemiology of hepatitis C virus infection","volume":"45","author":"Roudot-Thoraval","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106824_bib0074","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40263-021-00810-3","article-title":"Predicting infection risk in multiple sclerosis patients treated with Ocrelizumab: a retrospective cohort study","volume":"35","author":"Seery","year":"2021","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.msard.2025.106824_bib0075","first-page":"228","article-title":"Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation","volume":"12","author":"Shetty","year":"2012","journal-title":"Ochsner. J."},{"key":"10.1016\/j.msard.2025.106824_bib0076","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5217\/ir.2014.12.1.12","article-title":"Diagnosis and treatment of latent tuberculosis infection in patients with inflammatory bowel diseases due to initiation of anti-tumor necrosis Factor therapy","volume":"12","author":"Shim","year":"2014","journal-title":"Intest. Res."},{"key":"10.1016\/j.msard.2025.106824_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101963","article-title":"Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series","volume":"40","author":"Signoriello","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0078","first-page":"1","article-title":"Vaccination in multiple sclerosis \u2011 challenging practices (Review)","volume":"20","author":"Sirbu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.msard.2025.106824_bib0079","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1007\/s10072-022-06197-3","article-title":"Comparative safety of high-efficacy disease-modifying therapies in relapsing\u2013remitting multiple sclerosis: a systematic review and network meta-analysis","volume":"43","author":"\u015aladowska","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106824_bib0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40121-017-0182-x","article-title":"Negative IgG Varicella zoster virus antibody status: immune responses pre and post re-immunization","volume":"7","author":"Smith-Norowitz","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.msard.2025.106824_bib0081","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11910-021-01117-y","article-title":"Infection mitigation strategies for Multiple sclerosis patients on oral and monoclonal disease-modifying therapies","volume":"21","author":"Smith","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.msard.2025.106824_bib0082","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/13524585221150881","article-title":"Safety of COVID-19 vaccines in multiple sclerosis: a systematic review and meta-analysis","volume":"29","author":"Stefanou","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106824_bib0083","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3346\/jkms.2014.29.1.38","article-title":"Safe re-administration of tumor necrosis factor-alpha (TNF\u03b1) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-tnf\u03b1 therapy","volume":"29","author":"Suh","year":"2014","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.msard.2025.106824_bib0084","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic Hepatitis B infection","volume":"319","author":"Tang","year":"2018","journal-title":"JAMa"},{"key":"10.1016\/j.msard.2025.106824_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101866","article-title":"Two cases of meningitis associated with ocrelizumab therapy","volume":"38","author":"Theriault","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0086","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106824_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103449","article-title":"Multiple sclerosis and pregnancy: pathogenesis, influencing factors, and treatment options","volume":"22","author":"Wang","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2025.106824_bib0088","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/CON.0000000000001136","article-title":"Epidemiology and pathophysiology of Multiple sclerosis","volume":"28","author":"Ward","year":"2022","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.msard.2025.106824_bib0089","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211039648","article-title":"Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)","volume":"14","author":"Wiendl","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2025.106824_bib0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/key394","article-title":"Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases","volume":"58","author":"Wijetilleka","year":"2019","journal-title":"Rheumatology."},{"key":"10.1016\/j.msard.2025.106824_bib0091","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/ijms22083859","article-title":"Current immunological and clinical perspective on vaccinations in multiple sclerosis patients: are they safe after all?","volume":"22","author":"Witman Tsur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106824_bib0092","series-title":"Guidelines On the Management of Latent Tuberculosis Infection","author":"Organization","year":"2025"},{"key":"10.1016\/j.msard.2025.106824_bib0093","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.3748\/wjg.v20.i22.6716","article-title":"Hepatitis C virus reactivation in cancer patients in the era of targeted therapies","volume":"20","author":"Yazici","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.msard.2025.106824_bib0094","first-page":"170","article-title":"The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)","volume":"111","author":"Zellweger","year":"2020","journal-title":"Med. Lav."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:32:03Z","timestamp":1781076723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":94,"alternative-id":["S2211034825005668"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106824","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS \u2013infectious disease group","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106824"}}